Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The FUTURE of ErbB-1 and ErbB-2 pathway inhibition in breast cancer: targeting multiple receptors.

× No keyword cloud information.

3 in total

1. The cancer treatment revolution.

Authors: David G Nathan
Journal: Trans Am Clin Climatol Assoc Date: 2007

2. Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer.

Authors: Masakazu Toi; Jeff Sperinde; Weidong Huang; Shigehira Saji; John Winslow; Xueguang Jin; Yuping Tan; Shinji Ohno; Seigo Nakamura; Hiroji Iwata; Norikazu Masuda; Kenjiro Aogi; Satoshi Morita; Christos Petropoulos; Michael Bates
Journal: BMC Cancer Date: 2010-02-23 Impact factor: 4.430

3. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy.

Authors: J Rafael Sierra; Virna Cepero; Silvia Giordano
Journal: Mol Cancer Date: 2010-04-12 Impact factor: 27.401

3 in total